tyramine has been researched along with dermatan sulfate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Berti, C; Casu, B; Guerrini, M; Harenberg, J; Malsch, R; Naggi, A; Torri, G | 1 |
Casu, B; Guerrini, M; Harenberg, J; Malsch, R; Naggi, A; Piazolo, L; Torri, G | 1 |
2 review(s) available for tyramine and dermatan sulfate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Synthesis and biological effects of N-alkylamine-labeled low-molecular-mass dermatan sulfate.
Topics: Animals; Anticoagulants; Cattle; Dermatan Sulfate; Molecular Weight; Swine; Tyramine | 1997 |
1 other study(ies) available for tyramine and dermatan sulfate
Article | Year |
---|---|
Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivative.
Topics: Animals; Anticoagulants; Dermatan Sulfate; Flow Cytometry; Fluorescein; Fluorescent Dyes; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Humans; Leukocytes; Male; Rats; Rats, Sprague-Dawley; Tyramine | 2002 |